EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Intrinsic Therapeutics Grabs $18M

Spinal implant developer Intrinsic Therapeutics has pulled in $18 million of a $20 million mixed offering of equity, options, and warrants, according to a filing with the SEC. Existing Intrinsic investors New Enterprise Associates, Spray Venture Partners, and New Leaf Venture Partners are listed as directors on the filing. The Woburn, MA-based company, which produces a prosthetic to treat disc herniation, closed a $21 million Series D round in summer 2007.